definiens: shall mean ( a ) wi th respect to a Monotherapy ANG2 Product, the ANG2 Antibody included therein ; ( b ) wi th respect to a Fixed Combination ANG2 Product, the ANG2 Antibody and Aflibercept and/or PDGF Licensed Product(s ), and any other active ingredients includ ed therein ; or ( c ) with respect to any other Licensed Product, including, without limitation, any other F ixed Combination ANG2 Product, each of the ANG2 Antibody and, if applicable, Aflibercept and/or PDGF Licens ed Product(s ), and any other active ingredients includ ed therein, in each case ( ( a ), ( b ) and ( c ) ), formul ated into solution or in lyophilized form, ready for storage and/or shipment to a manufacturing facility, to all ow processing into the Finished Product